Search results
Cyrus S. Poonawalla (born in 1941) is an Indian billionaire businessman, and the chairman and managing director of the Cyrus Poonawalla Group, which includes the Serum Institute of India, an Indian biotech company which is the largest vaccine manufacturer in the world and Poonawalla Fincorp a leading NBFC in India.
Learn about Cyrus Poonawalla, the founder of Serum Institute of India, the world's largest vaccine maker by doses. See his net worth, age, education, family and quotes.
One of India's biggest houses, no match for Mukesh Ambani's Rs 15000 crore Antilia, it's worth Rs..., owner is...
Mumbai is home to numerous luxurious properties owned by business tycoons and celebrities. Among the...
DNA India
16 hours ago
Ataash bags the J.E. Hughes Trophy
Trainer Nazaak B. Chenoy's Ataash wins J.E. Hughes Trophy in Pune races on July 28, 2024.
The Hindu
3 days ago
Learn how Cyrus Poonawalla, the chairman of Serum Institute of India, built a vaccine empire that supplies immunization for millions of people worldwide. From horse breeding to car racing, discover his diverse interests and achievements in this success story.
Cyrus Poonawalla Group is among India's top private sector business houses serving over millions of people across financial services, vaccine manufacturing, pharmaceutical, renewable energy, real estate & hospitality sectors.
People also ask
Who is Cyrus Poonawalla?
Who are Cyrus & Adar Poonawalla?
Who founded Cyrus Poonawalla Group?
Who is the father of Cyrus Poonawalla?
Learn about Dr. Cyrus Poonawalla, the richest healthcare billionaire in the world and the chairman of Poonawalla Group, which includes Serum Institute of India, the world's largest vaccine manufacturer. Find out his achievements, awards, and philanthropic activities.
Mar 10, 2021 · Learn how Cyrus Poonawalla, the founder of Serum Institute of India, became a global leader in vaccine production and distribution, including Covid-19 vaccines. Read his journey from horse breeding and car building to creating affordable and accessible immunisation for millions.